Gene · 429
Papers4,495
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 4,495
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Molecular subtypes and prognostic factors of lung large cell neuroendocrine carcinoma. | Transl Lung Cancer Res | 2024 | 39430332 | PubTator, text mining | PubMed |
| Epigenetic Insights into Autism Spectrum Disorder: DNA Methylation Levels of NR3C1, ASCL1, and FOXO3 in Korean Autism Spectrum Disorder Sibling Pairs. | Clin Psychopharmacol Neurosci | 2024 | 39420610 | PubTator, text mining | PubMed |
| The tumor immune microenvironment of SCLC is not associated with its molecular subtypes. | Eur J Cancer | 2024 | 39413714 | PubTator, text mining | PubMed |
| Bioinformatics approaches for studying molecular sex differences in complex diseases. | Brief Bioinform | 2024 | 39397573 | PubTator, text mining | PubMed |
| The neuroendocrine transition in prostate cancer is dynamic and dependent on ASCL1. | Nat Cancer | 2024 | 39394434 | PubTator, text mining | PubMed |
| Relationship between the expressions of DLL3, ASC1, TTF-1 and Ki-67: First steps of precision medicine at SCLC. | Oncotarget | 2024 | 39392394 | PubTator, text mining | PubMed |
| Unveiling the Molecular Features of SCLC With a Clinical RNA Expression Panel. | JTO Clin Res Rep | 2024 | 39386315 | PubTator, text mining | PubMed |
| HOXDeRNA activates a cancerous transcription program and super enhancers via genome-wide binding. | Mol Cell | 2024 | 39383879 | PubTator, text mining | PubMed |
| Enhancer landscape of lung neuroendocrine tumors reveals regulatory and developmental signatures with potential theranostic implications. | Proc Natl Acad Sci U S A | 2024 | 39361648 | PubTator, text mining | PubMed |
| Monocyte Invasion into the Retina Restricts the Regeneration of Neurons from Müller Glia. | J Neurosci | 2024 | 39353729 | PubTator, text mining | PubMed |
| ASCL1 Restrains ERK1/2 to Promote Survival of a Subset of Neuroendocrine Lung Cancers. | Mol Cancer Ther | 2024 | 39295275 | PubTator, text mining | PubMed |
| BCL2 expression is enriched in advanced prostate cancer with features of lineage plasticity. | J Clin Invest | 2024 | 39286979 | PubTator, text mining | PubMed |
| Neuroendocrine Differentiation in Prostate Cancer Requires ASCL1. | Cancer Res | 2024 | 39264686 | PubTator, text mining | PubMed |
| Redefining YAP1 in small cell lung cancer: shifting from a dominant subtype marker to a favorable prognostic indicator. | Transl Lung Cancer Res | 2024 | 39263025 | PubTator, text mining | PubMed |
| Single-cell landscape of intratumoral heterogeneity and tumor microenvironment remolding in pre-nodal metastases of breast cancer. | J Transl Med | 2024 | 39210391 | PubTator, text mining | PubMed |
| Characteristics of molecular subtypes and cinical outcomes in the immunotherapy Queue of extensive-stage small cell lung cancer patients. | BMC Pulm Med | 2024 | 39210380 | PubTator, text mining | PubMed |
| Association of Methylated DNA Markers with High-Risk HPV Infections in Oral Site and Precancer Anal Lesions in HIV-Positive MSM. | Biomedicines | 2024 | 39200302 | PubTator, text mining | PubMed |
| Rare presence and function of neuroendocrine cells in the nasal mucosa. | Front Immunol | 2024 | 39176088 | PubTator, text mining | PubMed |
| Specific multivalent molecules boost CRISPR-mediated transcriptional activation. | Nat Commun | 2024 | 39174527 | PubTator, text mining | PubMed |
| Jumonji histone demethylases are therapeutic targets in small cell lung cancer. | Oncogene | 2024 | 39154123 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/429/papers?page=16